HSBC cuts Lupin price target 10% but keeps Buy
HSBC lowered its Lupin price target by 10% to ₹2,500 from ₹2,770, citing valuation concerns, while keeping a “buy” recommendation. Shares fell on Tuesday, Sept. 22.
Shares of Lupin Ltd. fell on Tuesday, September 22, after HSBC cut its price target on the drugmaker but kept its "buy" recommendation on the stock. HSBC trimmed its price target on Lupin by 10% to ₹2,500 from ₹2,770 earlier, citing valuation concerns.